Skip to main content
. Author manuscript; available in PMC: 2014 Aug 14.
Published in final edited form as: J Cyst Fibros. 2008 Nov 20;8(1):1–8. doi: 10.1016/j.jcf.2008.10.002

Figure 2. Overview of potential anti-inflammatory strategies for the treatment of cystic fibrosis.

Figure 2

CF, cystic fibrosis; CFTR cystic fibrosis transmembrane conductance regulator; ENaC, epithelium sodium channel; TLR toll-like receptor, NFκB, nuclear factor kappa B; LTB4, leukotriene B4; ROS, reactive oxygen species; NETS, neutrophil extracellular traps; CDK1, cyclin dependent kinase 1.

HHS Vulnerability Disclosure